163 related articles for article (PubMed ID: 24470143)
1. Bone matrix quality after sclerostin antibody treatment.
Ross RD; Edwards LH; Acerbo AS; Ominsky MS; Virdi AS; Sena K; Miller LM; Sumner DR
J Bone Miner Res; 2014 Jul; 29(7):1597-607. PubMed ID: 24470143
[TBL] [Abstract][Full Text] [Related]
2. Bone Matrix Composition Following PTH Treatment is Not Dependent on Sclerostin Status.
Ross RD; Mashiatulla M; Robling AG; Miller LM; Sumner DR
Calcif Tissue Int; 2016 Feb; 98(2):149-57. PubMed ID: 26514840
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones.
Ominsky MS; Li C; Li X; Tan HL; Lee E; Barrero M; Asuncion FJ; Dwyer D; Han CY; Vlasseros F; Samadfam R; Jolette J; Smith SY; Stolina M; Lacey DL; Simonet WS; Paszty C; Li G; Ke HZ
J Bone Miner Res; 2011 May; 26(5):1012-21. PubMed ID: 21542004
[TBL] [Abstract][Full Text] [Related]
4. Effect of anti-sclerostin therapy and osteogenesis imperfecta on tissue-level properties in growing and adult mice while controlling for tissue age.
Sinder BP; Lloyd WR; Salemi JD; Marini JC; Caird MS; Morris MD; Kozloff KM
Bone; 2016 Mar; 84():222-229. PubMed ID: 26769006
[TBL] [Abstract][Full Text] [Related]
5. Progressive increases in bone mass and bone strength in an ovariectomized rat model of osteoporosis after 26 weeks of treatment with a sclerostin antibody.
Li X; Niu QT; Warmington KS; Asuncion FJ; Dwyer D; Grisanti M; Han CY; Stolina M; Eschenberg MJ; Kostenuik PJ; Simonet WS; Ominsky MS; Ke HZ
Endocrinology; 2014 Dec; 155(12):4785-97. PubMed ID: 25259718
[TBL] [Abstract][Full Text] [Related]
6. Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength.
Yao W; Dai W; Jiang L; Lay EY; Zhong Z; Ritchie RO; Li X; Ke H; Lane NE
Osteoporos Int; 2016 Jan; 27(1):283-294. PubMed ID: 26384674
[TBL] [Abstract][Full Text] [Related]
7. Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized rats.
Stolina M; Dwyer D; Niu QT; Villasenor KS; Kurimoto P; Grisanti M; Han CY; Liu M; Li X; Ominsky MS; Ke HZ; Kostenuik PJ
Bone; 2014 Oct; 67():305-13. PubMed ID: 25093263
[TBL] [Abstract][Full Text] [Related]
8. Tissue-level mechanisms responsible for the increase in bone formation and bone volume by sclerostin antibody.
Ominsky MS; Niu QT; Li C; Li X; Ke HZ
J Bone Miner Res; 2014 Jun; 29(6):1424-30. PubMed ID: 24967455
[TBL] [Abstract][Full Text] [Related]
9. Time-dependent effects of sclerostin antibody on a mouse fracture healing model.
Cui L; Cheng H; Song C; Li C; Simonet WS; Ke HZ; Li G
J Musculoskelet Neuronal Interact; 2013 Jun; 13(2):178-84. PubMed ID: 23728104
[TBL] [Abstract][Full Text] [Related]
10. Sclerostin antibody and interval treadmill training effects in a rodent model of glucocorticoid-induced osteopenia.
Achiou Z; Toumi H; Touvier J; Boudenot A; Uzbekov R; Ominsky MS; Pallu S; Lespessailles E
Bone; 2015 Dec; 81():691-701. PubMed ID: 26409255
[TBL] [Abstract][Full Text] [Related]
11. Rapidly growing Brtl/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment.
Sinder BP; Salemi JD; Ominsky MS; Caird MS; Marini JC; Kozloff KM
Bone; 2015 Feb; 71():115-23. PubMed ID: 25445450
[TBL] [Abstract][Full Text] [Related]
12. Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2.
Otomo H; Sakai A; Ikeda S; Tanaka S; Ito M; Phipps RJ; Nakamura T
J Bone Miner Metab; 2004; 22(5):404-14. PubMed ID: 15316861
[TBL] [Abstract][Full Text] [Related]
13. Increased bone formation and bone mass induced by sclerostin antibody is not affected by pretreatment or cotreatment with alendronate in osteopenic, ovariectomized rats.
Li X; Ominsky MS; Warmington KS; Niu QT; Asuncion FJ; Barrero M; Dwyer D; Grisanti M; Stolina M; Kostenuik PJ; Simonet WS; Paszty C; Ke HZ
Endocrinology; 2011 Sep; 152(9):3312-22. PubMed ID: 21733832
[TBL] [Abstract][Full Text] [Related]
14. Sclerostin Antibody Augments the Anabolic Bone Formation Response in a Mouse Model of Mechanical Tibial Loading.
Morse A; Schindeler A; McDonald MM; Kneissel M; Kramer I; Little DG
J Bone Miner Res; 2018 Mar; 33(3):486-498. PubMed ID: 29090474
[TBL] [Abstract][Full Text] [Related]
15. Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model.
Tian X; Jee WS; Li X; Paszty C; Ke HZ
Bone; 2011 Feb; 48(2):197-201. PubMed ID: 20850580
[TBL] [Abstract][Full Text] [Related]
16. Sclerostin antibody reduces long bone fractures in the oim/oim model of osteogenesis imperfecta.
Cardinal M; Tys J; Roels T; Lafont S; Ominsky MS; Devogelaer JP; Chappard D; Mabilleau G; Ammann P; Nyssen-Behets C; Manicourt DH
Bone; 2019 Jul; 124():137-147. PubMed ID: 31051315
[TBL] [Abstract][Full Text] [Related]
17. Effect of sclerostin antibody treatment in a mouse model of severe osteogenesis imperfecta.
Roschger A; Roschger P; Keplingter P; Klaushofer K; Abdullah S; Kneissel M; Rauch F
Bone; 2014 Sep; 66():182-8. PubMed ID: 24953712
[TBL] [Abstract][Full Text] [Related]
18. Sclerostin antibody treatment enhances bone strength but does not prevent growth retardation in young mice treated with dexamethasone.
Marenzana M; Greenslade K; Eddleston A; Okoye R; Marshall D; Moore A; Robinson MK
Arthritis Rheum; 2011 Aug; 63(8):2385-95. PubMed ID: 21484764
[TBL] [Abstract][Full Text] [Related]
19. Sclerostin monoclonal antibody enhanced bone fracture healing in an open osteotomy model in rats.
Suen PK; He YX; Chow DH; Huang L; Li C; Ke HZ; Ominsky MS; Qin L
J Orthop Res; 2014 Aug; 32(8):997-1005. PubMed ID: 24782158
[TBL] [Abstract][Full Text] [Related]
20. Sclerostin deficiency is linked to altered bone composition.
Hassler N; Roschger A; Gamsjaeger S; Kramer I; Lueger S; van Lierop A; Roschger P; Klaushofer K; Paschalis EP; Kneissel M; Papapoulos S
J Bone Miner Res; 2014 Oct; 29(10):2144-51. PubMed ID: 24753092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
